Axonics Modulation Technologies

Company profile

About

Axonics Modulation Technologies (NASDAQ:AXNX) specializes in developing and commercializing innovative neuromodulation products aimed at treating bladder and bowel dysfunction. The company's primary focus is on improving the lives of patients suffering from these conditions through advanced medical technology. Axonics has dedicated itself to research and development to continuously enhance its product offerings, aligning with its objective to set new standards in the neuromodulation industry. Their efforts are encapsulated in their Sacral Neuromodulation (SNM) system, a notable project designed to offer a minimally invasive solution to patients, showcasing the company's commitment to innovation and quality healthcare solutions.

Snapshot

2012Year founded

665Employees

Irvine, United StatesHead office

Loading Map...

Global footprint

Operations

All Locations

Irvine, US

Products and/or services of Axonics Modulation Technologies

Sacral neuromodulation systems for bladder and bowel control.
Rechargeable sacral neuromodulation (SNM) system designed for a 15-year life.
Non-rechargeable SNM system offering a low-maintenance treatment option.
Advanced programming and patient remote control for personalized therapy management.
Innovative urethral bulking agent for stress urinary incontinence.
Comprehensive patient support services including education and training.